Anteris Technologies Global (AVR) vs InMode (INMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Anteris Technologies Global (AVR) has outperformed InMode (INMD) over the past year, gaining 38.7% versus a loss of 6.4%. InMode is the larger company by market cap ($810.2 million vs $646.1 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AVR | INMD |
|---|---|---|
| Share price | $6.63 | $14.08 |
| Market cap | $646.15M | $810.22M |
| 1-day change | -2.79% | +0.50% |
| YTD return | +32.87% | -4.15% |
| 1-year return | +38.70% | -6.45% |
| 5-year return | — | -83.11% |
| P/E ratio (TTM) | — | 11.64 |
| Forward P/E | — | 10.26 |
| EPS (TTM) | $-1.95 | $1.21 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $11.06 | $16.74 |
| 52-week low | $3.30 | $12.72 |
| Distance from 52-week high | -40.03% | -15.89% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +111.16% | +14.84% |
| Average volume | 913.27K | 521.98K |
| Shares outstanding | 97.46M | 57.54M |
| Employees | 174 | 660 |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- AVR has outperformed INMD by 45.1 percentage points over the past year.
About Anteris Technologies Global
AVR stock →Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve.
Health Care · Industrial Specialties · 174 employees
About InMode
INMD stock →InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 660 employees
AVR vs INMD FAQ
Which is bigger, Anteris Technologies Global or InMode?
InMode (INMD) is larger, with a market capitalization of $810.22M compared with $646.15M for Anteris Technologies Global (AVR).
Which stock has performed better over the past year, AVR or INMD?
AVR returned +38.70% over the past 12 months, compared with -6.45% for INMD (price return, excluding dividends). Past performance does not predict future results.
Are Anteris Technologies Global and InMode in the same industry?
Both are in the Health Care sector, but in different industries: Industrial Specialties for Anteris Technologies Global and Biotechnology: Electromedical & Electrotherapeutic Apparatus for InMode.